SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001020
Filing Date
2024-02-13
Accepted
2024-02-13 08:10:45
Documents
16
Period of Report
2024-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20240213x8k.htm   iXBRL 8-K 38748
2 EX-99.1 mgtx-20240213xex99d1.htm EX-99.1 15238
3 GRAPHIC mgtx-20240213xex99d1001.jpg GRAPHIC 3029
  Complete submission text file 0001558370-24-001020.txt   183178

Data Files

Seq Description Document Type Size
4 EX-101.SCH mgtx-20240213.xsd EX-101.SCH 3120
5 EX-101.LAB mgtx-20240213_lab.xml EX-101.LAB 15927
6 EX-101.PRE mgtx-20240213_pre.xml EX-101.PRE 10052
17 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20240213x8k_htm.xml XML 4863
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 24622669
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)